The popular weight-loss medication Wegovy will soon be available to telehealth companies. ABC News' Dr. Darien Sutton breaks ...

Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

The ‘SkinnyTok’ weight-loss trend is raising red flags among health experts, who caution it could encourage food deprivation ...

Ready to transform your body? It's possible with this program's personalized care, telehealth consultations, and semaglutide ...

After old photos of himself helped him realize just how much he'd given up, he decided to get back on track the only way he ...

White House Director of Communications Steven Cheung responded harshly to a CNN guest's comment about President Donald ...

Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

Blue Cross Blue Shield of Massachusetts, the state's largest health insurer, recently announced that it will roll back ...

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...